LabCompass

Shihyoung Kim

Medicine · The Ohio State University

OpenAlex ORCID
Early career · publishing since 2020
CAR-T cell therapy researchT-cell and B-cell ImmunologyRNA modifications and cancerToxin Mechanisms and ImmunotoxinsCancer-related molecular mechanisms research

Publications

13

Citations

99

Est. group size

~13

Recurring co-author estimate

Active years

6

Publishing since 2020

Research summary
AI-generated

Shihyoung Kim's research focuses on immunology and molecular biology approaches relevant to HIV and cancer, including engineering immune cells, using toxins to deplete specific immune cell populations, and studying RNA modifications on viral genetic material. The work often involves animal models (such as rhesus macaques) and gene-modified blood stem cells to explore potential therapies.

HIV-1 molecular biology and RNA modificationImmune cell engineering (e.g., CAR-T and stem cell gene therapy)Immunotoxin-based cell depletionCancer-related molecular mechanismsT-cell and B-cell immunology

Publication output has been modest but fairly steady over the last five years, with a small increase in activity since 2022 after a gap earlier in the decade.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
1718192020: 1 publication20212022: 3 publications3222023: 2 publications232024: 2 publications242025: 1 publication2526
Recent publications
Publishes in
  • Nature Microbiology×1
  • Advanced Science×1
  • Methods and Protocols×1
  • Science Advances×1
  • Biomedicines×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile